Rochelle K Rosen1, Jacob J van den Berg2, Sara E Vargas3, Natali Senocak4, Julia G Shaw5, Robert W Buckheit6, Kelley Alison Smith7, Kate Morrow Guthrie8. 1. Centers for Behavioral and Preventive Medicine, The Miriam Hospital, Coro West, Suite 309, 164 Summit Avenue, Providence, RI 02906, USA; Department of Behavioral and Social Sciences, Brown University School of Public Health, Providence, RI 02906, USA. Electronic address: rrosen@lifespan.org. 2. Centers for Behavioral and Preventive Medicine, The Miriam Hospital, Coro West, Suite 309, 164 Summit Avenue, Providence, RI 02906, USA; Department of Psychiatry and Human Behavior, The Warren Alpert Medical School of Brown University, Providence, RI 02903, USA. Electronic address: jvandenberg@lifespan.org. 3. Centers for Behavioral and Preventive Medicine, The Miriam Hospital, Coro West, Suite 309, 164 Summit Avenue, Providence, RI 02906, USA; Department of Psychiatry and Human Behavior, The Warren Alpert Medical School of Brown University, Providence, RI 02903, USA. Electronic address: svargas@lifespan.org. 4. Centers for Behavioral and Preventive Medicine, The Miriam Hospital, Coro West, Suite 309, 164 Summit Avenue, Providence, RI 02906, USA. Electronic address: natalisenocak@gmail.com. 5. Centers for Behavioral and Preventive Medicine, The Miriam Hospital, Coro West, Suite 309, 164 Summit Avenue, Providence, RI 02906, USA. Electronic address: julia.shaw@gmail.com. 6. ImQuest BioSciences, Inc., 7340 Executive Way, Suite R, Frederick, MD 21704, USA. Electronic address: rbuckheit@imquestbio.com. 7. Centers for Behavioral and Preventive Medicine, The Miriam Hospital, Coro West, Suite 309, 164 Summit Avenue, Providence, RI 02906, USA. Electronic address: ksmith20@lifespan.org. 8. Centers for Behavioral and Preventive Medicine, The Miriam Hospital, Coro West, Suite 309, 164 Summit Avenue, Providence, RI 02906, USA; Department of Behavioral and Social Sciences, Brown University School of Public Health, Providence, RI 02906, USA; Department of Psychiatry and Human Behavior, The Warren Alpert Medical School of Brown University, Providence, RI 02903, USA. Electronic address: kmorrow@lifespan.org.
Abstract
OBJECTIVE: Users' sensory perceptions and experiences of intravaginal products can inform acceptability and adherence. Focusing on the meanings women derive from formulation/device characteristics facilitates developers' design iterations toward optimizing user experience. We investigated how users of long-acting gels and intravaginal rings (IVRs) impute meaning to characteristics that may affect future product use. STUDY DESIGN: Focus groups were conducted with contraceptive IVR and vaginal lubricant users. Current perceptibility science and historical theory on the cultural acceptability of fertility regulating methods informed the analysis. RESULTS: A total of 21 IVR users and 29 lubricant users attended focus groups in which they manipulated products in their hands and discussed reactions to product characteristics. Participants used prior product experiences and sensory perceptions of prototype manipulations to inform meanings about product properties and performance for pregnancy, disease prevention, comfort, and perceived efficacy. The meanings derived from product characteristics depended on why the product would be used; a characteristic deemed problematic in one risk context may be considered preferable in another. CONCLUSIONS: Intravaginal product users create narratives that ascribe influence or causality to product characteristics. These meanings, whether correct or incorrect biologically, will shape vaginal product acceptability, use, and effectiveness. IMPLICATIONS: Long-acting and sustained-release drug delivery systems will be part of the multipurpose prevention continuum. Developers must consider how sensory experiences and culturally salient assumptions shape the meanings users make of product design characteristics. Those meanings will ultimately impact use and effectiveness.
OBJECTIVE: Users' sensory perceptions and experiences of intravaginal products can inform acceptability and adherence. Focusing on the meanings women derive from formulation/device characteristics facilitates developers' design iterations toward optimizing user experience. We investigated how users of long-acting gels and intravaginal rings (IVRs) impute meaning to characteristics that may affect future product use. STUDY DESIGN: Focus groups were conducted with contraceptive IVR and vaginal lubricant users. Current perceptibility science and historical theory on the cultural acceptability of fertility regulating methods informed the analysis. RESULTS: A total of 21 IVR users and 29 lubricant users attended focus groups in which they manipulated products in their hands and discussed reactions to product characteristics. Participants used prior product experiences and sensory perceptions of prototype manipulations to inform meanings about product properties and performance for pregnancy, disease prevention, comfort, and perceived efficacy. The meanings derived from product characteristics depended on why the product would be used; a characteristic deemed problematic in one risk context may be considered preferable in another. CONCLUSIONS: Intravaginal product users create narratives that ascribe influence or causality to product characteristics. These meanings, whether correct or incorrect biologically, will shape vaginal product acceptability, use, and effectiveness. IMPLICATIONS: Long-acting and sustained-release drug delivery systems will be part of the multipurpose prevention continuum. Developers must consider how sensory experiences and culturally salient assumptions shape the meanings users make of product design characteristics. Those meanings will ultimately impact use and effectiveness.
Authors: Quarraisha Abdool Karim; Salim S Abdool Karim; Janet A Frohlich; Anneke C Grobler; Cheryl Baxter; Leila E Mansoor; Ayesha B M Kharsany; Sengeziwe Sibeko; Koleka P Mlisana; Zaheen Omar; Tanuja N Gengiah; Silvia Maarschalk; Natasha Arulappan; Mukelisiwe Mlotshwa; Lynn Morris; Douglas Taylor Journal: Science Date: 2010-07-19 Impact factor: 47.728
Authors: Catherine M Montgomery; Mitzy Gafos; Shelley Lees; Neetha S Morar; Oliver Mweemba; Agnes Ssali; Jonathan Stadler; Robert Pool Journal: Cult Health Sex Date: 2010-08
Authors: L Van Damme; A Wright; K Depraetere; I Rosenstein; V Vandersmissen; L Poulter; M McKinlay; E Van Dyck; J Weber; A Profy; M Laga; V Kitchen Journal: Sex Transm Infect Date: 2000-04 Impact factor: 3.519
Authors: Rochelle K Rosen; Kathleen M Morrow; Alex Carballo-Diéguez; Joanne E Mantell; Susie Hoffman; Fang Gai; Lisa Maslankowski; Wafaa M El-Sadr; Kenneth H Mayer Journal: J Womens Health (Larchmt) Date: 2008-04 Impact factor: 2.681
Authors: Toral Zaveri; Cordelia A Running; Lahari Surapaneni; Gregory R Ziegler; John E Hayes Journal: Drug Deliv Transl Res Date: 2016-10 Impact factor: 4.617
Authors: Sara E Vargas; Miriam M Midoun; Melissa Guillen; Melissa L Getz; Kristen Underhill; Caroline Kuo; Kate M Guthrie Journal: Perspect Sex Reprod Health Date: 2019-05-20
Authors: Kate M Guthrie; Joseph L Fava; Sara E Vargas; Rochelle K Rosen; Julia G Shaw; Erna M Kojic; Anthony S Ham; Lisa C Rohan; David Katz; Anacecilia Panameño; Christopher Colleran; David F Friend; Karen W Buckheit; Robert W Buckheit Journal: AIDS Res Hum Retroviruses Date: 2020-11-03 Impact factor: 2.205
Authors: Kate M Guthrie; Rochelle K Rosen; Sara E Vargas; Melissa Guillen; Arielle L Steger; Melissa L Getz; Kelley A Smith; Jaime J Ramirez; Erna M Kojic Journal: Drug Deliv Transl Res Date: 2017-10 Impact factor: 4.617
Authors: Imogen Hawley; Mei Song; Rachel Scheckter; Tara McClure; Jeanna Piper; Beatrice A Chen; Craig Hoesley; Albert Y Liu; Ariane van der Straten Journal: AIDS Res Hum Retroviruses Date: 2022-02-11 Impact factor: 1.723
Authors: Sofía L Carbone; Melissa Guillen; Jaime J Ramirez; Sara E Vargas; Connie Fei Lu; Melissa L Getz; Yaa Frimpong; Kelley A Smith; Claire Stout; Iris Tong; Melanie Hill; Robert E Berry; Abigail Harrison; Kate M Guthrie Journal: Sex Health Date: 2020-06 Impact factor: 2.706
Authors: Kate Morrow Guthrie; Sara Vargas; Julia G Shaw; Rochelle K Rosen; Jacob J van den Berg; Patrick F Kiser; Karen Buckheit; Dana Bregman; Lara Thompson; Kathleen Jensen; Todd Johnson; Robert W Buckheit Journal: PLoS One Date: 2015-12-22 Impact factor: 3.240
Authors: Rachel J Primrose; Toral Zaveri; Alyssa J Bakke; Gregory R Ziegler; Howard R Moskowitz; John E Hayes Journal: PLoS One Date: 2016-03-21 Impact factor: 3.240